Survival benefit with resection of brain metastases from renal cell carcinoma in the setting of molecular targeted therapy and/or immune therapy

Publication date: Available online 18 November 2021

Source: Current Problems in Cancer

Author(s): Kristin Huntoon, Mark Damante, Joshua Wang, Thomas Olencki, J. Bradley Elder

Go to Source

This article was first shared by INDoximity

You may also like...

Enable Notifications    OK No thanks